技术指标
指标
数值
方向
MACD(12,26,9)
-0.028
中性
RSI(14)
62.378
中性
STOCH(KDJ)(9,3,3)
57.592
中性
ATR(14)
0.035
高波动
CCI(14)
110.765
买入
Williams %R
33.333
买入
TRIX(12,20)
0.025
卖出
StochRSI(14)
99.923
买入
搜索
Organon & Co
OGN添加自选
13.550USD
+0.005+0.04%
收盘 07-31 16:00（美东）报价延迟15分钟
3.56B总市值
14.35市盈率 TTM
关键数据
13.550今开
13.570最高
2.69M成交量
14.35市盈率 TTM
3.63市盈率动
0.080股息TTM
1.03%换手率
13.550昨收
13.540最低
22.60M成交额
4.08市盈率静
4.69市净率
0.59%股息率 TTM
1.88%ROA
13.48052周最高
1.11量比
864.00M净利润
260.32M总股本
0.9440每股收益TTM
1.53Beta
34.05%ROE
5.69052周最低
0.22%振幅
54.36%毛利率
3.56B总市值
-0.02回报/风险
3.01%风险率
TradingKey Organon & Co股票评分
单位: USD 更新时间: 2026-07-31操作建议
Organon & Co当前公司基本面数据相对稳定，增长潜力很大。当前估值合理，在药品行业排名69/155位。机构持股占比非常高，近一月多位分析师给出公司评级为持有。最高目标价10.80。中期看，股价处于平稳状态。近一个月，市场表现一般，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Organon & Co评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
Organon & Co亮点
亮点风险
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.
高分红
公司属于高分红公司，最新股息支付率34.38%
估值高估
公司最新PE估值14.35，处于3年历史高位
机构减仓
最新机构持股239.27M股，环比减少1.64%
欧文·卡恩持仓
明星投资者欧文·卡恩持仓，最新持仓市值2.48M
分析师目标
根据
6
位分析师
持有
评级
10.800
目标均价
-20.24%
涨幅空间
Organon & Co新闻
即将为您带来更多新闻，敬请期待。。。
收益预测
分析师评级
根据
6
位分析师
持有
评级
10.800
目标均价
-20.24%
涨幅空间
强力买入
买入
持有
卖出
强力卖出
同行比较
160
总数
6
中位数
9
平均值
公司名称
评级分布
分析师数
Organon & Co
OGN
6
安进
AMGN
37
Biogen Inc
BIIB
37
礼来
LLY
34
艾伯维
ABBV
32
辉瑞
PFE
32
1
2
3
...
32
技术指标
移动平均线
指标
数值
方向
MA5
13.540
买入
MA10
13.530
买入
MA20
13.517
买入
MA50
13.466
买入
MA100
11.375
买入
MA200
9.549
买入
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Organon & Co简介
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.
公司代码OGN
公司Organon & Co
CEOMorrissey (Joseph T)
网址https://www.organon.com/
公司股东
相关品种
热门品种
常见问题
Organon & Co(OGN)的当前股价是多少？
Organon & Co(OGN)的当前股价是 13.55。
Organon & Co的股票代码是什么？
Organon & Co的股票代码是OGN。
Organon & Co股票的52周最高点是多少？
Organon & Co股票的52周最高点是13.48。
Organon & Co股票的52周最低点是多少？
Organon & Co股票的52周最低点是5.69。
Organon & Co的市值是多少？
Organon & Co的市值是3.53B。
现在Organon & Co(OGN)的股票是买入、持有还是卖出？
根据分析师评级，Organon & Co(OGN)的总体评级为signal_hold，目标价格为10.80。
Organon & Co(OGN)股票的每股收益（EPS TTM）是多少
Organon & Co(OGN)股票的每股收益（EPS TTM）是0.72。